Publications

Mind the funding gap: who is paying the health workers?

Achieving an adequate, fair funding level for a strong health workforce in Malawi

Report - 17/12/2018

Public finance targets for universal health coverage

What level of public finance is needed for universal health coverage (UHC)?

Fact sheet - 15/12/2018

Finance for a Sustainable Health Workforce

About the global health workforce crisis, health systems, and universal health coverage. How can we achieve a sustainable health workforce?

Video - 14/9/2018

National plan endocrine-disrupting chemicals (in Dutch)

National plan endocrine-disrupting chemicals in a circulair economy to protect public health.

Report - 9/9/2018

Infographic on financing for health

Financing for health (SDG3): shared global responsibility – an analysis of five African countries

Infographic - 17/5/2018

Framing the Health Workforce Agenda Beyond Economic Growth

Article by Remco van de Pas, Linda Mans, Mariëlle Bemelmans, Anja Krumeich

Article - International journal of health policy and management - 16/5/2018

Year overview 2017

The Wemos year overview of 2017

Report - 10/5/2018

Annual report 2017

The Wemos annual financial report of 2017

Report - 10/5/2018

Factsheet ‘Introduction to Health Labour Market Analysis’

Information on the Health Labour Market approach and on the factors that influence the need, demand for and supply of health workers.

Fact sheet - 2/5/2018

Factsheet The WHO Code of Practice on the International Recruitment of Health Personnel

Information on the WHO Code of Practice on the International Recruitment of Health Personnel

Fact sheet - 1/5/2018

Factsheet Global Agreements

An overview of global agreements on Human Resources for Health policies in 2010-2018 to address the growing need for health workers.

Fact sheet - 1/5/2018

Infographic paying for Universal Health Coverage

Paying for Universal Health Coverage: a pool for a plan

Infographic - 21/4/2018

World Health Organization: current issues and advocacy opportunities

A position paper on the WHO for civil society organizations

Report - 17/4/2018

Civil society contributions to a sustainable health workforce in the European Union

By Linda Mans, Remco van de Pas, and Sascha Marschang. Published in Public Health Panorama 2017; 3(3):357-536

Article - Public Health Panorama - 9/9/2017

Independent clinical research: a road towards affordable & valuable medicines

Why we advocate independent clinical research of new medicines

Article - 3/9/2017

Clinical trials in Africa

The cases of Egypt, Kenya, Zimbabwe and South Africa

Report - 3/7/2017

Annual report 2016

The Wemos annual report of 2016

Article - 10/5/2017

Transnational pharmaceutical companies’ clinical drug trials in Egypt

Ethical questions in a challenging context. By Pearl Heinemans, Irene Schipper and Patrick Durisch.

Article - Dirty Profits 5 - 10/2/2017

Industry-sponsored clinical drug trials in Egypt

Ethical questions in a challenging context. A joint study by Public Eye, SOMO, Egyptian Initiative for Personal Rights, Shamseya for Innovative Community Healthcare Solutions, and Wemos.

Report - 10/12/2016

What you should know about endocrine-disrupting chemicals (in Dutch)

Information about endocrine-disrupting chemicals, made in collaboration with Vrije Universiteit Amsterdam

Fact sheet - 18/11/2016

The Code of Practice and its enduring relevance in Europe and Eastern and Southern Africa

By Remco van de Pas, Linda Mans, e.a.

Article - Biomed Central - 17/7/2016

Measures against endocrine disrupting chemicals

The example of Denmark, Sweden and France. Joint publication with WECF and Pesticide Action Network

Report - 22/6/2016

Clinical trials in Africa: an exploitative relationship

By Annelies den Boer en Amy Davies

Article - Dirty Profits 4, 2016 - 3/6/2016

Annual report 2015

The Wemos annual report of 2015 (in Dutch)

Report - 10/5/2016

Project results: Health Workers 4 All

Country and joint activities and results of this European project 2013-2015

Report - 25/4/2016

Wemos strategy 2016-2020

The Wemos strategy for 2016-2020 (in Dutch)

Report - 1/1/2016

Wemos strategy 2016-2020 short version

Short version of the Wemos strategy 2016-2020 (in Dutch)

Article - 1/1/2016

‘Adaptive licensing’ or ‘adaptive pathways’: deregulation under the guise of earlier access

Position paper by Health Action International, ISDB, the Medicines in Europe Forum, the Mario Negri Institute for Pharmacological Research, the Nordic Cochrane and Wemos

Report - 15/10/2015